Profile data is unavailable for this security.
About the company
Syncona Limited is a Guernsey-based closed-ended investment company. The Company’s investment objective is to achieve superior long-term capital appreciation from its investments. It seeks to achieve returns over the long term. The Company invests in life science businesses (including private and quoted companies) and single or multi-asset projects. It focuses on creating, building and scaling companies around science to create a diversified portfolio of 20-25 global healthcare businesses, across development stage and therapeutic areas. It focuses on developing treatments for patients by working in close partnership with academic founders and management teams. The Company makes its life science investments through Syncona Holdings Limited, a subsidiary of the Company. It maintains its capital pool through Syncona Investments LP Incorporated (the Partnership), in which the Company is the sole limited partner. Syncona Investment Management Limited is its investment manager.
- Revenue in GBP (TTM)-67.18m
- Net income in GBP-93.58m
- Incorporated2012
- Employees0.00
- LocationSyncona Limited3Rd FloorArnold House, St Julian's AvenuePO Box 273SAINT PETER PORT GY1 3RDGuernseyGGY
- Websitehttps://www.synconaltd.com/
Profile
| Management group(s) | Syncona Investment Management Limited |
|---|---|
| AIC sector | Biotechnology & Healthcare |
| ISIN | GG00B8P59C08 |
| Launch date | 26 Oct 2012 |
| Share type | Ordinary Share |
| Structure | Investment Trust |
| Base currency | GBP |
Objective
The Company’s investment objective is to achieve superior long-term capital appreciation from its investments. The Company invests in life science businesses and single or multi-asset projects. The Company targets an annualised return per share across its investment portfolio of 15 per cent per annum over the long term.
Managed by
| Chris Hollowood |
|---|
Management & contract fees
The company will pay SIML an annual fee
Peer analysis
| Company | Revenue (TTM) | Net income (TTM) |
|---|---|---|
| Aberdeen Asia Focus PLC | 98.07m | 89.94m |
| SDCL Efficiency Income Trust PLC | 48.20m | 36.70m |
| Blackrock Greater Eurp Invstmnt Trst PLC | -32.63m | -40.20m |
| BlackRock Smaller Companies Trust plc | -83.39m | -90.59m |
| Pollen Street Group Ltd | 127.94m | 53.95m |
| Hansa Investment Company Ltd | 30.07m | 23.01m |
| Schroder Asian Totl Retrn Invstmt Co PLC | 10.03m | -1.07m |
| VinaCapital Vietnam Opportunity Fund Ltd | -21.15m | -34.96m |
| Jpmorgan European Discovery Trust PLC | 128.14m | 118.28m |
| Partners Group Private Equity Ltd | 37.94m | 8.27m |
| Syncona Ltd | -67.18m | -93.58m |
| JPMorgan European Growth & Income PLC | 96.85m | 90.88m |
| Polar Capital Holdings plc | 228.66m | 39.10m |
| GCP Infrastructure Investments Ltd | 33.72m | 18.36m |
| Brunner Investment Trust Plc | 22.98m | 16.51m |
| NB Private Equity Partners Ltd | 63.30m | 36.49m |
Institutional shareholders
| Holder | Shares | % Held |
|---|---|---|
| The Wellcome Trust Ltd. (Investment Management)as of 31 Mar 2025 | 186.00m | 30.58% |
| BlackRock Investment Management (UK) Ltd.as of 05 Jun 2025 | 54.43m | 8.95% |
| Schroder Investment Management Ltd.as of 31 Mar 2025 | 33.49m | 5.51% |
| Towers Watson Investment Management Ltd.as of 30 Dec 2025 | 11.89m | 1.96% |
| Columbia Threadneedle Management Ltd.as of 31 Oct 2025 | 10.18m | 1.67% |
| Threadneedle Asset Management Ltd.as of 31 Dec 2025 | 10.11m | 1.66% |
| W1m Investment Management Ltd.as of 31 Oct 2025 | 9.26m | 1.52% |
| T. Rowe Price Hong Kong Ltd.as of 30 Sep 2025 | 7.28m | 1.20% |
| Liontrust Investment Partners LLPas of 28 Nov 2025 | 6.79m | 1.12% |
| Vanguard Asset Management Ltd.as of 31 Dec 2025 | 5.53m | 0.91% |
